Some People – Mainly Children – Have Pre-existing Coronavirus Antibodies That Could Help Protect Against COVID-19

Protection Against COVID-19

Scientists found that some people, especially children, have antibodies against SARS-CoV-2 in their blood, despite never being infected. These antibodies likely result from exposure to other coronaviruses that cause common colds and share similarities with SARS-CoV-2.

Researchers at the Francis Crick Institute and University College London have found that some antibodies, created by the immune system during infection with common cold coronaviruses, can also target SARS-CoV-2 and may confer a degree of protection against the new viral strain.

In response to infection with a virus, the immune system creates antibodies to help fight it. These antibodies remain in the blood for a period after infection, and in the case of re-infection, they are able to tackle the virus again.

In their paper, published in Science today (Friday, November 6, 2020), the scientists found that some people, notably children, have antibodies reactive to SARS-CoV-2 in their blood, despite not ever having been infected with the virus. These antibodies are likely the result of exposure to other coronaviruses, which cause a common cold and have structural similarities with SARS-CoV-2.

The researchers made this discovery while developing highly sensitive antibody tests for COVID-19. To see how well their assay tests were performing, they compared the blood of patients with COVID-19 to patients who had not had the disease. Surprisingly, they found that some people who had not been exposed to SARS-CoV-2 had antibodies in their blood that would recognize the virus. To confirm their findings, they analyzed over 300 blood samples collected before the pandemic, between 2011 and 2018.

Nearly all samples had antibodies that reacted with common cold coronaviruses, which was expected given how everyone has been exposed to these viruses at some point in their lives. However, a small fraction of adult donors, about 1 in 20, also had antibodies that cross-reacted with SARS-CoV-2, and this was not dependent on recent infection with a common cold coronavirus.*

Notably, such cross-reactive antibodies were found much more frequently in blood samples taken from children aged 6 to 16.

Kevin Ng, lead author and post-graduate student in the Retroviral Immunology Laboratory at the Crick says: “Our results show that children are much more likely to have these cross-reactive antibodies than adults. More research is needed to understand why this is, but it could be down to children being more regularly exposed to other coronaviruses.

“These higher levels we observed in children could also help explain why they are less likely to become severely ill with COVID-19. There is no evidence yet, however, that these antibodies prevent SARS-CoV-2 infection or spread.”

In the lab, the researchers tested the antibodies they found in the blood from uninfected people to confirm they were able to neutralize SARS-CoV-2. They found the cross-reactive antibodies target the S2 subunit of the spike protein on the surface of the virus.

George Kassiotis, senior author and group leader of the Retroviral Immunology Laboratory at the Crick says: “The spike of this coronavirus is made of two parts or subunits, performing different jobs. The S1 subunit allows the virus to latch onto cells and is relatively diverse among coronaviruses, whereas the S2 subunit lets the virus into cells and is more similar among these viruses. Our work shows that the S2 subunit is sufficiently similar between common cold coronaviruses and SARS-CoV-2 for some antibodies to work against both.

“It was previously thought that only antibodies to the S1 could block infection, but there is now good evidence that some antibodies to S2 can be just as effective. This is exciting as understanding the basis for this activity could lead to vaccines that work against a range of coronaviruses, including the common cold strains, as well as SARS-CoV-2 and any future pandemic strains.

“But it is important to stress that there are still many unknowns which require further research. For example, exactly how is immunity to one coronavirus modified by exposure to another? Or why does this activity decline with age? It is not the case that people who have recently had a cold should think they are immune to COVID-19.”

A large study is now underway, in partnership with researchers at Imperial College London and University College London, to uncover the role that different antibodies and other immune defenses play in protection against COVID-19 and how severely ill people become.


* The researchers found that:

  • In samples taken from 50 pregnant women in May 2018, 10% had cross-reactive antibodies.
  • 21 of 48 blood samples taken from children aged 1 to 16 between 2011 and 2018 contained these cross-reactive antibodies
  • An additional cohort of 13 adult donors recently infected with other coronaviruses, only one tested positive for these cross-reactive antibodies.

Reference: “Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans” by Kevin W. Ng, Nikhil Faulkner, Georgina H. Cornish, Annachiara Rosa, Ruth Harvey, Saira Hussain, Rachel Ulferts, Christopher Earl, Antoni G. Wrobel, Donald J. Benton, Chloe Roustan, William Bolland, Rachael Thompson, Ana Agua-Doce, Philip Hobson, Judith Heaney, Hannah Rickman, Stavroula Paraskevopoulou, Catherine F. Houlihan, Kirsty Thomson, Emilie Sanchez, Gee Yen Shin, Moira J. Spyer, Dhira Joshi, Nicola O’Reilly, Philip A. Walker, Svend Kjaer, Andrew Riddell, Catherine Moore, Bethany R. Jebson, Meredyth Wilkinson, Lucy R. Marshall, Elizabeth C. Rosser, Anna Radziszewska, Hannah Peckham, Coziana Ciurtin, Lucy R. Wedderburn, Rupert Beale, Charles Swanton, Sonia Gandhi, Brigitta Stockinger, John McCauley, Steve J. Gamblin, Laura E. McCoy, Peter Cherepanov, Eleni Nastouli and George Kassiotis, 6 November 2020, Science.
DOI: 10.1126/science.abe1107

2 Comments on "Some People – Mainly Children – Have Pre-existing Coronavirus Antibodies That Could Help Protect Against COVID-19"

  1. I find it ludicrous,unethical and amoral profiteering that drug companies and blood collection agencies, notably CSI, want we covid19 survivors to DONATE FREE our blood/antibodies while they charge sick patients $226,000 for the treatment!
    Why isn’t the “media” on this?
    NEVER UNDERESTIMATE the power of ignorance!

    • Fights Against In-Humanity | November 13, 2020 at 5:16 pm | Reply

      @Kevin Simala: That’s the way you said that is totally linear with how can Red Cross ask me to DONATE FREE our blood while they charge $xxx,xxx for the multi trauma accident victim which need serial operating procedures.

      Why isn’t the “media” on this?

      NEVER UNDERESTIMATE the power of inhumanity!

Leave a comment

Email address is optional. If provided, your email will not be published or shared.